INS and type 2 diabetes mellitus: The decrease in the proportion of patients taking sulfonylureas and the increase in those on insulin therapy have two likely explanations: the slight increase observed in hypoglycaemia among patients with type 1 diabetes and the increasing proportion of patients with type 2 diabetes being treated with insulin rather than insulin secretagogues.